Although The NTSB Is Absolutely Correct On Mandatory Sleep Apnea Testing And "Successful Treatment", It Is Practically Impossible To Implement These Mandatory Certifications Without More Practical Solutions Because More Than 60% Of Sleep Apnea Patients Can Not Tolerate The Gold Standard Sleep Apnea CPAP Therapy. More Than 50% Of Commercial Pilots And Drivers May Forever Lose Their Pilot's Or Driver's Licenses Unless They Are Provided With More Practical Solutions Beside Surgeries And A Lifelong CPAP Face Mask.
Hanover Park, IL (PRWEB) November 4, 2009 - Dr. Jin Zhou of SleepApneaUSA.net announced an alternative, potential sleep apnea solution for commercial pilots and drivers. The NTSB recently recommended mandatory sleep apnea certification for sleep apnea testing and subsequent "successful treatment" after the two pilots of northwest airlines flight 188 overshot their destination airport, Minneapolis, by 150 miles on October 21, 2009. Both have since lost their pilot licenses. "Although the NTSB is absolutely correct by mandating sleep apnea testing and "successful treatment" based on well-known scientific facts and current sleep apnea knowledge as well as the long history of transportation accidents caused by sleep apnea patients", said Dr. Jin Zhou, "it is practically impossible to implement these mandatory certifications without more practical solutions available, because more than 60% of sleep apnea patients can't tolerate the gold standard sleep apnea therapy, which is sleeping with a CPAP face mask for life". And the CPAP does not cure sleep apnea patients, it affords only temporary relief. And more than 50% of commercial pilots may lose their pilot's license forever after the new mandates are enacted as federal laws. Therefore, unless absolutely federally involuntary mandated, most commercial pilots are not expected to voluntarily go through sleep apnea testing, which may mean immediate suspension or forever loss of their pilot's license. The same consequences would be true for all commercial drivers in the U.S.A.. Dr. Jin Zhou urged the federal government, the FMCSA, the FTA, the FAA, all airlines, the scientific and medical communities as well as the insurance industry to immediately seek more practical solutions, in addition to the currently available surgical and CPAP options to alleviate or cure sleep apnea. If possible, all of the commercial pilots with sleep apnea should be effectively controlled or cured with new options, especially since many won't tolerate standard CPAP therapy or invasive surgeries.
The NTSB made the same sleep apnea recommendations indirectly to The Coast Guard. "Actually, the NTSB sleep apnea recommendation should be scientifically correct and practically more important, as our national security, to all U.S. military pilots and combat personnel, after reported death of a soldier due to inoperable CPAP in Iraq", said Dr. Jin Zhou, a former orthopedic surgeon with the China Air Force General Hospital in Beijing, China 21 years ago.
Sleep apnea is a deadly illness without timely diagnosis and proper treatment, however, the current standard medical treatments are only focused on the surgeries and expensive, lifetime devices, with very limited clinical results and they are only for less than 30% of the sleep apnea population. Dr. Jin Zhou recently offered a Sleep Apnea ZHT Certification Class for healthcare providers as the no-surgery and no-device alternative for sleep apnea patients who could not tolerate or benefit from the standard sleep apnea medical treatment which consists of surgery and CPAP or oral devices.
Sleep apnea has been scientifically reported to be linked with the most of the CDC Top 10 death-cause medical diagnoses and traffic accidents as well as the spending of billions of dollars for treating sleep apnea related medical conditions and from the labor production losses by sleep apnea resulted sickness and disabilities. Very sadly, millions of Americans already diagnosed with sleep apnea could not tolerate with or benefit from the standard medical treatment by the surgery and CPAP or any oral devices.
It was estimated that more than 95-97% of sleep apnea sufferers were never diagnosed. Even for those patients already diagnosed with sleep apnea, it was reported that only less than 20% of them have good tolerance and compliance with the prescribed gold CPAP therapy, and more than 60% to 80% of patients already diagnosed with sleep apnea have no or poor tolerance with or benefit from the standard medical treatment with CPAP or surgery.
It is now reasonably well-known and established that sleep apnea has been linked to most of the CDC top 10 death-cause medical conditions, such as heart attack, cancer, stroke and diabetes. However, the original or ultimate cause for sleep apnea is not clearly known at all to the scientists and health care practitioners. Dr. Jin Zhou challenges the popular or mainstream theory in etiology for sleep apnea that obstruction or collapse of the upper airway is due to the weakened and enlarged soft palate. As a matter of fact, as Dr. Jin Zhou hypothesized, the clinical reality is the exact opposite or completely different, therefore the current mainstream clinical treatment protocols by surgery and CPAP or oral devices are not expected to ultimately cure sleep apnea but simply to provide for some limited or short-term relief or temporarily cover up the deterioration of sleep apnea development.
In developing the new ZHT (Zhou's Hypoxicology Therapy) treatment of sleep apnea, Dr. Zhou, observed clinically that trachea caudal displacement (TCD) (the windpipe moving downward), resulted from diaphragm malfunction and baroreflex dysfunction, instead of weakened soft appellate as claimed by the mainstream scientists, is the main anatomical pathology for snoring, collapse of the upper airway and frequent breathing stops during the night for people with obstructive sleep apnea. And as Dr. Zhou hypothesized, in addition, the dysfunction of the baroreflex, chemoreflex, metabo-reflex, mechanoreflex, psychosomato-reflex and respiration pace-making malfunction, due to psychological, environmental and anatomical causations, are primarily and intricately responsible for the obstructive and central sleep apnea development. Dr. Zhou further hypothesized that all of these sleep apnea etiological components are primarily controlled or regulated internally by the human body but induced externally. Therefore, sleep apnea should be completely reversible primarily through volitional resuscitation, resetting of the baroreflex and revitalization of the upper airway defense reflex by working through patient's body internally instead of externally through surgeries and devices.
ZHT, Zhou's Hypoxicology Therapy, as pioneered by its creator, Dr. Jin Zhou, is a new scientific concept and pioneering (aka, unproven) clinical solution as an alternative approach for sleep apnea. ZHT was noticed to be clinically beneficial not only to those sleep apnea patients but also to those patients with commonly seen medical conditions, from headache to sciatica, and mysteriously hard to treat medical conditions as a result of hypoxia, baroreflex dysfunction and dysautonomia.
Although it is not legally and scientifically permissible to claim ZHT as a new standard medical protocol, according to Dr. Jin Zhou, it is clinically and optimistically observed that ZHT therapy shall be safe and effective or otherwise ZHT should be discontinued if a patient is not responding to ZHT with definitely noticeable relief on the first session and with satisfactory and significant results within three sessions.
Dr. Jin Zhou, D.C., M.D. (China), a former orthopedic surgeon 21 years ago in China and currently a licensed chiropractic physician in Illinois for the last 18 years, is dedicated to developing a revolutionary breakthrough, an extremely simple and super natural therapy that could potentially save millions of lives and trillions of dollars without only relying on any medication, surgery and device. He coined the new word, hypoxicology. Dr. Zhou is also a nationally renowned expert in healthcare compliance and reimbursement. Dr. Jin Zhou is the president of ERISAclaim.com.
For more information, please visit http://sleepapneausa.net/ZHT_Certifcation.htm, or contact Dr. Jin Zhou at 630-808-7237.
Read the full story at http://www.prweb.com/releases/2009/11/prweb3158094.htm.
Copyright©2009 Vocus, Inc.
All rights reserved